Focusing on technologies that help prevent, diagnose and treat diseases
The Capricorn Health-tech Fund focuses on non-digital technologies that help prevent, diagnose and treat diseases (while the Capricorn Digital Growth Fund focuses on digital health technologies). The human healthcare technology sector comprises a diverse range of products and services in sub-sectors such as biopharmaceutical and pharmaceutical drugs, vaccines, medical devices, medical imaging, diagnostics, research equipment and nutraceuticals.
The fund has € 42 million committed capital and is fully invested
PortfolioView all portfolio items
Mainstay MedicalMedical Devices
iSTAR MedicalMedical Devices
Confo TherapeuticsPlatform Technology
Encouraging the development of medical procedures and drugs for emerging countries and ageing populationsJos B. Peeters
Our ambition is to encourage the development of novel medical procedures and drugs, which meet a major demand in all economies. On the one hand, this demand is fueled by the global increase in life expectancy which has created an elderly Western population struggling with chronic diseases. The rise in lifespan will continue to present significant growth opportunities for human healthcare technology companies. On the other hand, the Capricorn Health-tech Fund responds to the fact that more people in emerging economies can now afford proper medical treatment.